(Q63404415)
Statements
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-design Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type (English)
0 references
13 October 2017
0 references
June 2021
0 references
412
0 references
50 year
0 references
90 year
0 references